The disproportional distribution of far advanced stages (cancers with > 4 involved lymph nodes) in the prevalence screen < age 50 years is highly significant and supports the doubts concerning correct randomisation.
← all excerpts
Conclusions for mammography screening after 25-year follow-up of the Canadian National Breast Cancer Screening Study (CNBSS).
1
—
—